These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 17601317)
1. [Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo]. Tedeholm H; Skoog B; Hillert J; Runmarker B; Stawiarz L; Oluf A Lakartidningen; 2007 May 30-Jun 3; 104(22):1684-8. PubMed ID: 17601317 [No Abstract] [Full Text] [Related]
2. [Long-term prevention of MS: effectiveness alone is not enough]. Haas J Krankenpfl J; 2005; 43(7-10):237. PubMed ID: 16515307 [No Abstract] [Full Text] [Related]
3. Disease-modifying drugs for the early treatment of multiple sclerosis. Flachenecker P Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542 [TBL] [Abstract][Full Text] [Related]
4. Approaches to neuroprotective strategies in multiple sclerosis. Tselis A; Khan OA; Lisak RP Expert Opin Pharmacother; 2010 Dec; 11(17):2869-78. PubMed ID: 20687779 [TBL] [Abstract][Full Text] [Related]
5. Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments. Achiron A; Barak Y; Gail M; Mandel M; Pee D; Ayyagari R; Rotstein Z Breast Cancer Res Treat; 2005 Feb; 89(3):265-70. PubMed ID: 15754125 [TBL] [Abstract][Full Text] [Related]
6. [Drug therapy of multiple sclerosis]. Kinnunen E Duodecim; 1999; 115(4):403-7. PubMed ID: 11830889 [No Abstract] [Full Text] [Related]
14. Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis. Banwell B; Tremlett H Neurology; 2005 Mar; 64(5):778-9. PubMed ID: 15753408 [No Abstract] [Full Text] [Related]
15. A practical approach to immunomodulatory therapy for multiple sclerosis. Burks JS Phys Med Rehabil Clin N Am; 2005 May; 16(2):449-66, ix. PubMed ID: 15893681 [TBL] [Abstract][Full Text] [Related]
19. Betaseron: a breakthrough treatment for multiple sclerosis. Morrison W; Nelson J Can Nurse; 1996 Oct; 92(9):38-41. PubMed ID: 9118060 [TBL] [Abstract][Full Text] [Related]
20. Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis. Tan H; Cai Q; Agarwal S; Stephenson JJ; Kamat S Adv Ther; 2011 Jan; 28(1):51-61. PubMed ID: 21153000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]